Drugmaker Cephalon Completes $443.9M Settlement With DOJ, States Related To Allegations Of Improper Sales, Marketing Practices
Cephalon on Monday completed a $443.9 million settlement with federal and state regulators related to allegations of improper sales and marketing practices, the Wall Street Journal reports. Under the settlement, first disclosed in November 2007, Cephalon agreed with the Office of the U.S. attorney in Philadelphia and the
More: continued here